This item requires a subscription to Journal of Pharmacology and Experimental Therapeutics.
Full Text (PDF)
M L Cohen,
D W Robertson,
W E Bloomquist,
and H C Wilson
LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays
occlusion in a rabbit model of thrombosis. J Pharmacol Exp Ther April 1992 261:202-208